Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ppd Inc (PPD)

Ppd Inc (PPD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,496,624
  • Shares Outstanding, K 349,654
  • Annual Sales, $ 4,031 M
  • Annual Income, $ 47,820 K
  • 60-Month Beta N/A
  • Price/Sales 2.88
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PPD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.23
  • Number of Estimates 4
  • High Estimate 0.24
  • Low Estimate 0.21
  • Prior Year 0.32
  • Growth Rate Est. (year over year) -28.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.12 +2.37%
on 10/30/20
37.51 -12.34%
on 10/13/20
-4.11 (-11.11%)
since 09/30/20
3-Month
28.84 +14.01%
on 07/31/20
37.51 -12.34%
on 10/13/20
+3.67 (+12.56%)
since 07/30/20

Most Recent Stories

More News
Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)

--Moderna thanks PPD, its CRO partner, for the successful execution of COVE Study enrollment

MRNA : 67.47 (-5.35%)
PPD : 32.88 (-0.81%)
NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials

NEO : 39.23 (-5.13%)
PPD : 32.88 (-0.81%)
PPD Looks Good: Stock Adds 5.2% in Session

PPD saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

AVXL : 5.90 (-1.34%)
PPD : 32.88 (-0.81%)
Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market

, /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, today announced it closed an oversubscribed funding round. Existing investors Lux Capital, Redmile Group, and PPD,...

AMGN : 216.94 (-0.40%)
PPD : 32.88 (-0.81%)
PPD, Inc. Announces Offering of Senior Notes

PPD, Inc. (Nasdaq:PPD) (the "Company"), a leading global contract research organization, today announced that it intends to offer $700 million in aggregate principal amount of senior notes (the "Notes"),...

PPD : 32.88 (-0.81%)
Teladoc's (TDOC) Q1 Earnings Miss Estimates, Revenues Beat

Teladoc's (TDOC) first-quarter earnings gain from higher revenues, partly offset by a rise in expenses.

TDOC : 196.46 (-9.84%)
OPGN : 2.13 (-1.39%)
ESTA : 25.03 (-0.87%)
PPD : 32.88 (-0.81%)

Business Summary

PPD Inc. is a contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. It serves pharmaceutical, biotechnology, medical device, academic and government organizations. PPD Inc. is based in NC, United States.

See More

Key Turning Points

2nd Resistance Point 34.00
1st Resistance Point 33.44
Last Price 32.88
1st Support Level 32.22
2nd Support Level 31.56

See More

52-Week High 37.51
Last Price 32.88
Fibonacci 61.8% 27.23
Fibonacci 50% 24.06
Fibonacci 38.2% 20.89
52-Week Low 10.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar